Amgen Inc (AMGN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
306.95 +1.18 (+0.39%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 305.00 -1.95 (-0.64%) 16:42 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 9,086,000 | 8,503,000 | 8,388,000 | 7,447,000 | 8,196,000 |
| Cost of Goods | 3,112,000 | 3,310,000 | 3,236,000 | 3,200,000 | 3,112,000 |
| Gross Profit | 5,974,000 | 5,193,000 | 5,152,000 | 4,247,000 | 5,084,000 |
| Operating Expenses | 3,663,000 | 3,146,000 | 3,243,000 | 3,256,000 | 3,813,000 |
| Operating Income | 2,311,000 | 2,047,000 | 1,909,000 | 991,000 | 1,271,000 |
| Interest Expense | 747,000 | 776,000 | 808,000 | 824,000 | 821,000 |
| Other Income | -782,000 | 1,830,000 | -307,000 | -235,000 | 402,000 |
| Pre-tax Income | 782,000 | 3,101,000 | 794,000 | -68,000 | 852,000 |
| Income Tax | 155,000 | 271,000 | 48,000 | 45,000 | 85,000 |
| Net Income Continuous | 627,000 | 2,830,000 | 746,000 | -113,000 | 767,000 |
| Net Income | $627,000 | $2,830,000 | $746,000 | $-113,000 | $767,000 |
| EPS Basic Total Ops | 1.17 | 5.27 | 1.39 | -0.21 | 1.43 |
| EPS Basic Continuous Ops | 1.17 | 5.27 | 1.39 | -0.21 | 1.42 |
| EPS Diluted Total Ops | 1.17 | 5.22 | 1.38 | -0.21 | 1.42 |
| EPS Diluted Continuous Ops | 1.17 | 5.22 | 1.38 | -0.21 | 1.42 |
| EPS Diluted Before Non-Recurring Items | 5.31 | 5.58 | 4.97 | 3.96 | 4.71 |
| EBITDA(a) | $3,708,000 | $3,443,000 | $3,309,000 | $2,390,000 | $2,651,000 |